Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: A randomised, controlled, double-blind, ascending dose and phase 2a study
doi:10.3390/antibiotics12081304 32
These medications are designed to act on biological pathways associated with the GLP-1 hormone, which is naturally released in the gastrointestinal tract after eating
They are made based on a personalized prescription that may not be commercially available elsewhere or when a drug appears on the FDAs shortage list
US$ 25.34
US$ 20.60
US$ 23.18
US$ 25.48
US$ 26.33
US$ 23.68
US$ 27.95
US$ 25.96
US$ 21.11
